MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Phase 2

Not yet recruiting

Conditions: Malignant Brain Neoplasm

Interventions: Procedure: Computed Tomography
Drug: Fluorodopa F 18
Procedure: Positron Emission Tomography

First Posted Date: 2024-10-31

Last Posted Date: 2024-10-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 47

Registration Number: NCT06667726

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

IL1 Inhibitor in Subjects with Cardiac Sarcoidosis

Phase 2

Withdrawn

Conditions: Cardiomyopathies

Interventions: Drug: IL1 inhibitor

First Posted Date: 2024-10-28

Last Posted Date: 2024-12-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT06660732

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase 2

Recruiting

Conditions: Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC V8

First Posted Date: 2024-10-28

Last Posted Date: 2024-11-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06660407

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Enabling Microbiomics- Driven Personalized Nutrition

Not yet recruiting

Conditions: Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Celiac Disease
Diarrhea
Constipation
Microbiome
Crohn's Disease
UC - Ulcerative Colitis
Microscopic Colitis
Functional Dyspepsia

First Posted Date: 2024-10-24

Last Posted Date: 2024-12-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 4001

Registration Number: NCT06657001

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications

Phase 1

Not yet recruiting

Conditions: Liver Transplant; Complications
Liver Diseases

Interventions: Drug: Autologous adipose derived mesenchymal stromal cells (AMSC)

First Posted Date: 2024-10-21

Last Posted Date: 2024-10-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06649864

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

Not Applicable

Recruiting

Conditions: Crohn's Disease
Abdominal Pain (AP)

First Posted Date: 2024-10-18

Last Posted Date: 2024-10-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 15

Registration Number: NCT06647615

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Not Applicable

Recruiting

Conditions: COVID-19 Immunisation
Influenza Vaccine

First Posted Date: 2024-10-17

Last Posted Date: 2024-11-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 117780

Registration Number: NCT06646406

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Phase 2

Recruiting

Conditions: Advanced Fallopian Tube Carcinoma
Advanced Fallopian Tube High Grade Serous Adenocarcinoma
Advanced Ovarian Carcinoma
Advanced Ovarian Carcinosarcoma
Advanced Ovarian Clear Cell Adenocarcinoma
Advanced Ovarian Endometrioid Adenocarcinoma
Advanced Ovarian High Grade Serous Adenocarcinoma
Advanced Primary Peritoneal Carcinoma
Advanced Primary Peritoneal High Grade Serous Adenocarcinoma
Fallopian Tube Carcinosarcoma

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Biological: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Procedure: Leukapheresis
Procedure: Magnetic Resonance Imaging
Biological: Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
Drug: Placebo Administration
Biological: Tetanus and Diphtheria Toxoids Adsorbed

First Posted Date: 2024-10-15

Last Posted Date: 2024-11-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 78

Registration Number: NCT06639074

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Not yet recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

First Posted Date: 2024-10-14

Last Posted Date: 2024-10-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT06640010

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Phase 2

Not yet recruiting

Conditions: Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Breast Carcinoma
Triple-Negative Breast Carcinoma

Interventions: Procedure: Biopsy of Breast
Procedure: Biospecimen Collection
Procedure: Breast Surgery
Drug: Chemotherapy
Procedure: Computed Tomography
Procedure: Contrast Enhanced Digital Mammography
Radiation: Hypofractionated Radiation Therapy
Procedure: Magnetic Resonance Imaging
Procedure: Positron Emission Tomography
Other: Survey Administration
Procedure: Tissue Collection
Procedure: Ultrasound Imaging

First Posted Date: 2024-10-10

Last Posted Date: 2024-10-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 120

Registration Number: NCT06635980

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy